Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ENCO

L&g Multi-strategy Enhan... (ENCO)

Date:
Sort by:
 Showing the most relevant articles for your search:LSE:ENCO
DateTimeSourceHeadlineSymbolCompany
09/09/20098:30AMPR Newswire (US)Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial WLSE:ENCO
08/31/20095:31PMPR Newswire (US)Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' EquityLSE:ENCO
08/27/20095:12PMPR Newswire (US)Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q FilingLSE:ENCO
07/01/20099:10AMPR Newswire (US)Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. BusinessLSE:ENCO
07/01/20099:10AMPR Newswire (US)Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. BusinessLSE:ENCO
05/19/20094:37PMPR Newswire (US)Encorium Reports First Quarter 2009 Financial ResultsLSE:ENCO
05/18/20094:05PMPR Newswire (US)Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. BusinessLSE:ENCO
05/07/20093:23PMPR Newswire (US)Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research TeamLSE:ENCO
10/06/20087:50AMPR Newswire (US)Encorium Announces Stock Buyback; Provides Business and Financial UpdateLSE:ENCO
10/01/20084:12PMPR Newswire (US)Encorium Announces Receipt of Nasdaq Letter Regarding Compliance with Nasdaq's Independent Director and Audit Committee RequiremLSE:ENCO
 Showing the most relevant articles for your search:LSE:ENCO